Keyphrases
Spectral Theory
100%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
100%
Mutational Landscape
100%
Oligometastases
100%
Tumor Protein p53 (TP53)
83%
Radiographic Progression-free Survival
66%
Castration-resistant Prostate Cancer
50%
Tumor
33%
Metastasis
33%
Incidence Rate
33%
Disease Spectrum
33%
Hazard Ratio
33%
Mutational Profile
33%
Metachronous
33%
Driver mutations
33%
Binary State
33%
Oligometastatic
33%
Biological Definition
33%
Improved Outcomes
16%
Disease Diagnosis
16%
Measurement Analysis
16%
Statistical Analysis
16%
DNA Double-strand Break Repair
16%
Commercially Available
16%
Treatment Decisions
16%
Multivariable
16%
Primary Tumor
16%
TP53 mutation
16%
Clinical Grade
16%
Lesion number
16%
Cancer Hazard
16%
Number of Metastases
16%
Sequencing Platforms
16%
Local Therapy
16%
Free Time
16%
Genomic Association
16%
Metastatic Site
16%
Cancer Continuum
16%
Oligometastatic Prostate Cancer
16%
Biochemically Recurrent
16%
Polymetastasis
16%
Clinical Outcomes
16%
Working Diagnosis
16%
Disease Burden
16%
Metastatic Lesions
16%
Micrometastatic
16%
Medicine and Dentistry
Prostate Cancer
100%
Progression Free Survival
50%
Metastatic Carcinoma
37%
Neoplasm
25%
Somatics
25%
Hazard Ratio
25%
Outcome Assessment
12%
Cell Cycle
12%
Primary Tumor
12%
Disease Burden
12%
Retrospective Study
12%
Local Therapy
12%
Diseases
12%
Double-Strand DNA Break
12%
Biochemistry, Genetics and Molecular Biology
Progression Free Survival
100%
Retrospective Study
25%
Wild Type
25%
Cell Cycle
25%
Sample Size
25%
Disease Burden
25%
Genomics
25%
Double-Strand DNA Break
25%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Progression Free Survival
50%
Diseases
37%
Neoplasm
25%
Retrospective Study
12%
Double Stranded DNA
12%
Primary Tumor
12%